NeuroPace, Inc. (NPCE) vs Senseonics Holdings, Inc. (SENS)

NeuroPace, Inc. and Senseonics Holdings, Inc. are both Medical Devices companies. NeuroPace, Inc. and Senseonics Holdings, Inc. are of similar size ($438.7M and $435.2M). Senseonics Holdings, Inc. grew revenue faster over the last twelve months: 90.6% against 21.7%. NeuroPace, Inc. has the higher net margin (−18.6% vs −225.3%) and the higher return on invested capital (−44.6% vs −2,152.1%). Across the 18 metrics below, NeuroPace, Inc. leads on 11 and Senseonics Holdings, Inc. on 7.

Valuation

Metric NPCE SENS Medical Devices median
P/E n/m n/m 23.22
P/S 4.06 9.35 2.34
P/B 35.13 5.03 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 4.16 8.14 2.24
Earnings yield (4.66%) (28.41%) (10.09%)
Free cash flow yield (2.78%) (21.33%) (8.47%)

Profitability

Metric NPCE SENS Medical Devices median
Gross margin 78.38% 54.87% 56.01%
Operating margin (13.33%) (223.22%) (15.03%)
Net margin (18.58%) (225.34%) (20.40%)
Free cash flow margin (11.29%) (199.47%) (7.24%)
Return on equity (122.05%) (118.24%) (15.32%)
Return on assets (18.82%) (66.88%) (19.72%)
Return on invested capital (44.64%) (2,152.05%) (10.33%)

Growth

Metric NPCE SENS Medical Devices median
Revenue growth (TTM) 21.65% 90.63% 8.80%
EPS growth (last fiscal year) 29.03% 30.83% 29.03%
Revenue growth, 5-year CAGR 19.44% 48.10% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NPCE SENS Medical Devices median
Debt to equity 4.97 0.62 0.07
Current ratio 4.94 6.74 2.50
Net debt to EBITDA 0.15 0.88 0.49

Dividend

Metric NPCE SENS Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric NPCE SENS Medical Devices median
Market cap 438.66m 435.15m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack